← Eichor
Condition: Immunologic Deficiency Syndrome Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Immunologic Deficiency Syndrome

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The MARVIN Chatbots to Provide Information for Different Health Conditions
NA · 2 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT05789901Natural History of Dysregulation and Aging of the Immune System in People With Trisomy 21 With and Without Thymectomy
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07416201The DART DELIVER-02 Study
Phase 1 · 3 location(s) · University of North Carolina, Chapel Hill · NCT07217379Study of Populations at Risk of Developing Chronic Hepatitis Linked to Chronic Enteric Virus Infection in Patients With
Phase N/A · 3 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06659588Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS
Phase 3 · 5 location(s) · Federal University of Health Science of Porto Alegre · NCT05814432Polypharmacy on Healthy Aging in People Living With HIV Over the Age of 75
NA · 1 location(s) · Centre Hospitalier Universitaire de Nice · NCT07388394Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodefic
Phase 1/Phase 2 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT01306019A Remotely Delivered Tai Chi/Qigong Intervention for Older People Living With HIV
NA · 1 location(s) · Florida International University · NCT06586619Quitting Matters Human Immunodeficiency Virus Hybrid Trial
NA · 1 location(s) · Wake Forest University Health Sciences · NCT06883097Gene Therapy for ADA-SCID Using an Improved Lentiviral Vector (Ivlv-ADA)
NA · 1 location(s) · Shenzhen Geno-Immune Medical Institute · NCT03645460A Single-arm, Dose-escalation Trial of Long-acting Recombinant Human IL-7 (NT-I7, Efineptakin Alfa) for Idiopathic CD4 L
Phase 1/Phase 2 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT05600920Apheresis of Patients With Immunodeficiency
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT01212055Accelerated ART Initiation for PWHIV Who Are Out of Care
Phase 4 · 4 location(s) · University of Missouri-Columbia · NCT06374758Strategies to AchieVe Viral Suppression for Youth With HIV
NA · 1 location(s) · Johns Hopkins University · NCT06886971Integrating HIV Prevention With TB Household Contact Evaluation in Uganda
NA · 1 location(s) · University of Washington · NCT07119359Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00006150Enhancing the Organizational Social Context to Improve Viral Suppression and Retention in HIV Care
NA · 1 location(s) · University of Pennsylvania · NCT06462807Text Education About Cardiovascular Health and HIV (TEACH-HIV)
NA · 2 location(s) · University of California, San Francisco · NCT05642858Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)
Phase 2 · 9 location(s) · New York Medical College · NCT03266640DOR/TDF/3TC Switch With M184V/I in People With Controlled HIV (Drive Off-Road)
Phase 2 · 4 location(s) · University Hospital, Caen · NCT06034938Study of Autophagy and the Effects of GALIG Gene Products in HIV-1 Infected Patients Who Are Under Antiretroviral Therap
Phase N/A · 1 location(s) · Centre Hospitalier Régional d'Orléans · NCT04160455TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic D
Phase 2 · 1 location(s) · Johns Hopkins All Children's Hospital · NCT04414046A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
Phase 2 · 123 location(s) · ViiV Healthcare · NCT07202546Evaluation of the Effect of Cordycepin on CD8+ Lymphocytopenia in Patients With Solid Tumors
Phase 2 · 1 location(s) · Second Affiliated Hospital of Soochow University · NCT07258160Testing the WeCare Intervention to Address Mental Health and Medication Adherence Challenges Among MSM in South Africa
NA · 1 location(s) · Emory University · NCT07226323Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)
Phase 1/Phase 2 · 7 location(s) · New York Medical College · NCT04197596Zn Supplementation in HIV Immunological Non Responders
NA · 1 location(s) · Parc de Salut Mar · NCT06612554Genetic Basis of Immunodeficiency
Phase N/A · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT00055172Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts
Phase 1 · 3 location(s) · Children's National Research Institute · NCT04691622Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa
Phase N/A · 1 location(s) · Swiss Tropical & Public Health Institute · NCT05881447
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.